Menu
GeneBe

2-47378939-A-G

Variant summary

Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PP3_ModeratePP5_Very_Strong

The NM_002354.3(EPCAM):​c.556-14A>G variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000953 in 1,153,664 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).

Frequency

Genomes: 𝑓 0.000033 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00010 ( 0 hom. )

Consequence

EPCAM
NM_002354.3 splice_polypyrimidine_tract, intron

Scores

2

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:10

Conservation

PhyloP100: -0.0690
Variant links:
Genes affected
EPCAM (HGNC:11529): (epithelial cell adhesion molecule) This gene encodes a carcinoma-associated antigen and is a member of a family that includes at least two type I membrane proteins. This antigen is expressed on most normal epithelial cells and gastrointestinal carcinomas and functions as a homotypic calcium-independent cell adhesion molecule. The antigen is being used as a target for immunotherapy treatment of human carcinomas. Mutations in this gene result in congenital tufting enteropathy. [provided by RefSeq, Dec 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 10 ACMG points.

PP3
Splicing scoreres supports a deletorius effect: Scorers claiming Pathogenic: max_spliceai. No scorers claiming Uncertain. No scorers claiming Benign.
PP5
Variant 2-47378939-A-G is Pathogenic according to our data. Variant chr2-47378939-A-G is described in ClinVar as [Likely_pathogenic]. Clinvar id is 157603.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47378939-A-G is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
EPCAMNM_002354.3 linkuse as main transcriptc.556-14A>G splice_polypyrimidine_tract_variant, intron_variant ENST00000263735.9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
EPCAMENST00000263735.9 linkuse as main transcriptc.556-14A>G splice_polypyrimidine_tract_variant, intron_variant 1 NM_002354.3 P1
EPCAMENST00000405271.5 linkuse as main transcriptc.640-14A>G splice_polypyrimidine_tract_variant, intron_variant 5
EPCAMENST00000456133.5 linkuse as main transcriptc.640-14A>G splice_polypyrimidine_tract_variant, intron_variant, NMD_transcript_variant 5
EPCAMENST00000490733.1 linkuse as main transcriptn.405-14A>G splice_polypyrimidine_tract_variant, intron_variant, non_coding_transcript_variant 3

Frequencies

GnomAD3 genomes
AF:
0.0000329
AC:
5
AN:
152060
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000764
AC:
19
AN:
248832
Hom.:
0
AF XY:
0.0000964
AC XY:
13
AN XY:
134840
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000291
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000545
Gnomad SAS exome
AF:
0.000132
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000107
Gnomad OTH exome
AF:
0.000165
GnomAD4 exome
AF:
0.000105
AC:
105
AN:
1001604
Hom.:
0
Cov.:
14
AF XY:
0.000104
AC XY:
54
AN XY:
518722
show subpopulations
Gnomad4 AFR exome
AF:
0.0000407
Gnomad4 AMR exome
AF:
0.0000227
Gnomad4 ASJ exome
AF:
0.000172
Gnomad4 EAS exome
AF:
0.0000801
Gnomad4 SAS exome
AF:
0.000118
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000124
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000329
AC:
5
AN:
152060
Hom.:
0
Cov.:
33
AF XY:
0.0000269
AC XY:
2
AN XY:
74260
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.000131
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000294
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000434
Hom.:
0
Bravo
AF:
0.0000491

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Congenital diarrhea 5 with tufting enteropathy Pathogenic:8
Likely pathogenic, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineAug 30, 2022The c.556-14A>G variant in EPCAM has been reported in 10 individuals with congenital tufting enteropathy, at least 3 of which were homozygous or had additional variants in EPCAM (Schnell 2013 PMID: 23462293, Salomon 2014 PMID: 24142340, Bodian 2017 PMID: 28701297). One of these individuals had absence of EPCAM cell surface expression (Bodian 2017 PMID: 28701297). It segregated with disease in 2 affected family members from 2 families (Salomon 2014 PMID: 24142340, Bodian 2017 PMID: 28701297). It has also been identified in 0.02% (1/5192) of East Asian and 0.01% (1/15268) of Latino chromosomes by gnomAD (http://gnomad.broadinstitute.org). This variant has also been reported in ClinVar (Variation ID 157603). Studies have shown that this intronic variant creates a new acceptor site within intron 5, which is predicted to create a framshift variant p.Tyr186PhefsX6. Studies have also shown that this variant causes loss of cell-surface EpCAM (Schnell 2013 PMID: 23462293, Salomon 2014 PMID: 24142340). In summary, although additional studies are required to fully establish its clinical significance, this variant meets criteria to be classified as likely pathogenic for autosomal recessive congenital tufting enteropathy. ACMG/AMP Criteria applied: PM3, PS3, PP1_Moderate. -
Pathogenic, no assertion criteria providedliterature onlyOMIMJul 01, 2013- -
Pathogenic, criteria provided, single submitterclinical testingInstitute of Human Genetics, University of Leipzig Medical CenterSep 17, 2019This variant was identified as homozygous -
Likely pathogenic, criteria provided, single submitterclinical testingGenomics Facility, Ludwig-Maximilians-Universität MünchenDec 28, 2021- -
Pathogenic, criteria provided, single submitterresearchITMIOct 10, 2016- -
Pathogenic, criteria provided, single submitterclinical testingSt. Jude Molecular Pathology, St. Jude Children's Research HospitalAug 02, 2023The EPCAM c.556-14A>G intronic change results in an A to G substitution at the -14 position of intron 5 of the EPCAM gene. Algorithms that predict the impact of sequence changes on splicing indicate that this change results in the creation of a splice acceptor site, which is predicted to cause a frameshift and the creation of a premature stop codon. This change is predicted to cause protein truncation or absence of protein due to nonsense-mediated decay. This variant has been reported in multiple individuals with congenital tufting enteropathy in the homozygous and compound heterozygous state (PMID: 23462293, 24142340, 26684320, 27848944, 28701297, 30461124). This variant has a maximum subpopulation frequency of 0.013% in gnomAD v2.1.1 (https://gnomad.broadinstitute.org). In summary, this variant meets criteria to be classified as pathogenic with respect to congenital tufting enteropathy and of uncertain significance with respect to Lynch syndrome since the evidence currently available is insufficient to determine the clinical significance of this variant with respect to Lynch syndrome. -
Pathogenic, criteria provided, single submitterclinical testingDepartment of Genetics, Rouen University Hospital, Normandy Center for Genomic and Personalized MedicineJul 06, 2022- -
Pathogenic, criteria provided, single submitterclinical testingSuma Genomics-- -
Lynch syndrome 8;C2750737:Congenital diarrhea 5 with tufting enteropathy Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsMay 25, 2022- -
not provided Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingInvitaeJan 10, 2019For these reasons, this variant has been classified as Pathogenic. In cDNA sequence analysis using patient-derived RNA, this variant resulted in a frameshift caused by abnormal splicing (PMID: 24142340). An experimental study using cells expressing the truncated protein (p.Tyr186Phefs*6) has shown that this truncated protein lacks the transmembrane domain of EPCAM, resulting in loss of cell-surface EPCAM protein, and reduced protein secretion in vitro (PMID: 23462293). This variant has been reported in multiple individuals affected with congenital tufting enteropathy (CTE) (PMID: 23462293, 24142340, 28701297). ClinVar contains an entry for this variant (Variation ID: 157603). This variant is present in population databases (rs376155665, ExAC 0.01%). This sequence change falls in intron 5 of the EPCAM mRNA. It has been shown to affect mRNA splicing through the creation of new splice acceptor site, which causes a frameshift at codon 186 and creates a premature translational stop signal (p.Tyr186Phefs*6) (PMID: 23462293, 24142340). It is expected to result in an absent or disrupted protein product. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Uncertain
25
DANN
Benign
0.56

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.96
Details are displayed if max score is > 0.2
DS_AG_spliceai
0.96
Position offset: 1

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs376155665; hg19: chr2-47606078; COSMIC: COSV55393327; COSMIC: COSV55393327; API